deCODE genetics, Inc.

deCODE genetics, Inc.

deCODE genetics, Inc. (deCODE) is a bio-pharmaceutical company developing and marketing products for the treatment, diagnosis, and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in therapeutic areas, and applies its discoveries in human genetics to bring to market deoxyribonucleic acid (DNA)-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. In November 2009, the Company announced that it has filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code with the United States Bankruptcy Court for the District of Delaware.

Contact Details

Office Address

deCODE genetics, Inc.
Sturlugata 8, Reykjavik, Iceland IS-101
Phone: +354-570-1900
Fax: +354-570-1903

Executives

Chairman, President, CEO, and Secretary

Kari Stefansson M.D.

CFO and Treasurer

Lance Thibault

Business Reviews for deCODE genetics, Inc.

Related Companies